Clinical trial
Post Transplant Study
NCT00395902 · Amgen, Industry · Completed
Key facts
| NCT number | NCT00395902 |
|---|---|
| Title | Post Transplant Study |
| Official title | A Retrospective Evaluation of Sensipar Use in Renal Transplant Recipients |
| Lead sponsor | Amgen, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Kidney Tansplant, Secondary Hyperparathyroidism, Hyperparathyroidism |
| Intervention type | Drug |
| Interventions | Sensipar after Post Transplant |
| Enrollment | 50 |
| Start date | Aug 1, 2005 |
| First posted | Nov 6, 2006 |
| Last update posted | Dec 28, 2007 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: